DIABETIC MEDICINE

Inhibition of cytokine-like protein 1 transcription hinders wound-healing process in diabetic rats
Xu J, Tong Y, Lin M, Zhang Z, Li T and Zhang F
This study explored the function and mechanism of cytokine-like protein 1 (CYTL1) in regulating the wound-healing process of rats with diabetes mellitus (DM).
A homozygous TARS2 variant is a novel cause of syndromic neonatal diabetes
Donis R, Patel KA, Wakeling MN, Johnson MB, Amoli MM, Yildiz M, Akçay T, Aspi I, Yong J, Yaghootkar H, Weedon MN, Hattersley AT, Flanagan SE and De Franco E
Neonatal diabetes is a monogenic condition which can be the presenting feature of complex syndromes. The aim of this study was to identify novel genetic causes of neonatal diabetes with neurological features including developmental delay and epilepsy.
Type 1 Diabetes in care homes: A practical guide on management
Sinclair AJ, Bellary S, Middleton A, Morris A, Walker R, Winkley Bryant K, Dashora U, Karamat M, Rayner J, Tomlinson S and Maltese G
The primary purpose of the original NAPCHD project was to develop a national Strategic Document of Diabetes Care for Care Homes which has now been completed and well received as a worthwhile, sustainable, and effective guidance for delivering quality diabetes care in the UK. A Working Group of NAPCHD was established to produce a Position Statement on type 1 diabetes in care homes since this area was recommended as a topic to further develop. There are currently limited data on the prevalence and clinical outcomes associated with type 1 diabetes in care homes and management policies have been non-existent in the UK. Communication among all key stakeholders involved in direct care of residents with type 1 diabetes is generally fragmented and lacks coordination. This is compounded by a slowly growing utilisation of diabetes technology and the absence of a standard/agreed community-based model of interdisciplinary collaboration. The Rationale and Objectives were defined prior to commencing the work and a work plan with individual tasks was initially set out. After multiple correspondences and Team calls over a period of 9 months, the Group successfully generated a first draft in October 2023. This draft was then finalised the following month and circulated among stakeholders for feedback. Nine chapters have been provided including minimum standards of diabetes care, insulin regimens, avoiding hospitalisation and discharge planning. A scheme for a community-based model of care for type 1 diabetes has been included. Eight key messages were developed. In addition, an Appendix has been created which includes key assessments such as nutritional assessment, detection of frailty, sick day rules and foot risk stratification (available online).
The impact of prolonged walking on fasting plasma glucose in type 2 diabetes: A randomised controlled crossover study
Niwaha AJ, Shields BM, Rodgers LR, Hattersley AT, Andrews RC, Nyirenda MJ and Jones AG
In many low-income countries, fasting glucose is the primary measure for monitoring glycaemic control. Many patients in these countries walk long distances to the clinic, but the impact of walking on fasting glucose in type 2 diabetes is unknown. We aimed to determine the impact of walking on fasting glucose in people with type 2 diabetes.
Investigating health professionals' perspectives and experiences of food security-related conversations in diabetes care
Mohamed S, Avenell A, Douglas F and Keen A
Household food insecurity (FI) is a serious public health concern and disproportionately affects people living with chronic health conditions, undermining diabetes self-management. Little is known about healthcare professionals' (HCPs) experiences of supporting people affected by diabetes and FI, and no national guidelines incorporate consideration of FI within UK diabetes care. A qualitative study of NHS HCPs' consideration of FI within diabetes care, and the extent to which it informs their clinical practice, was undertaken.
Sensor-derived glycaemic metrics in pregnant women with type 1 diabetes randomised to faster acting insulin aspart or insulin aspart-A secondary analysis of the CopenFast trial
Søholm JC, Nørgaard SK, Nørgaard K, Clausen TD, Damm P, Mathiesen ER and Ringholm L
We compared sensor-derived glycaemic metrics in pregnant women with type 1 diabetes (T1D) randomised to faster acting insulin aspart (faster aspart) or insulin aspart (IAsp).
Managing diabetic chronic kidney disease in pregnancy: Current clinical practice and uncertainties
Banerjee A and Brackenridge A
Pre-gestational diabetes occurs in approximately 1% of pregnancies in the UK and increases the risk of adverse maternal and fetal outcomes. More women with type 2 than type 1 diabetes are now becoming pregnant and tend to have higher rates of obesity and other multi-morbidities. Chronic kidney disease (CKD) affects approximately 5%-10% of pregnant women with type 1 diabetes and about 2%-3% with type 2 diabetes. Diabetic chronic kidney disease (DCKD) increases the risk of preeclampsia, preterm birth, Caesarean section, small for gestational age (SGA) infant and infant admission to neonatal intensive care unit (NICU), and risks are higher compared to those with diabetes without CKD and those with CKD from other causes. Definitions of CKD in pregnancy are not standardised, and studies are generally small, observational, heterogenous, mainly include women with type 1 diabetes and often predate modern diabetes management such as continuous glucose monitoring and insulin pumps. Therefore, there is a lack of robust data to guide practice and clinical guidelines offer conflicting advice, without precise detail.
Evaluating a mental health support mobile app for adults with type 1 diabetes living in rural and remote communities: The REACHOUT pilot study
Tang TS, Klein G, Görges M, Yip A, Fisher L, Polonsky WH, Hessler D and Taylor D
To evaluate a mobile app that delivers mental health support to adults with type 1 diabetes (T1D) living in rural and remote communities using the Reach, Effectiveness, Adoption, Intervention fidelity, Maintenance (RE-AIM) framework.
Diabetes distress and depression in type 2 diabetes. A cross-sectional study in 18,000 individuals in the Central Denmark region
Dalsgaard EM, Graversen SB, Bjerg L, Sandbaek A and Laurberg T
Type 2 diabetes is linked to psychological distress and a doubled risk of depression. This study aims to characterize individuals with type 2 diabetes experiencing diabetes distress and/or depression in relation to lifestyle and metabolic outcomes.
Characterisation of islet antibody-negative type 1 diabetes mellitus in Indian children
Menon JC, Singh P, Archana A, Kanga U, Singh P, Mittal M, Garg A, Seth A, Bhatia V, Dabadghao P, Sudhanshu S, Vishwakarma R, Verma S, Singh SK and Bhatia E
Islet antibody-negative type 1 diabetes mellitus (T1DM) has not been well characterised. We determined the frequency of antibody-negative T1DM and compared it with antibody-positive T1DM in a cohort of north Indian children.
Prevalence and risk factors for impaired awareness of hypoglycaemia: A registry-based study of 10,202 adults with type 1 diabetes in Norway
Hernar I, Strandberg RB, Nilsen RM, Cooper JG, Skinner TC, Iversen MM, Richards DA, Lie SS, Løvaas KF, Madsen TV, Ueland GÅ and Haugstvedt A
The aim of this study is to determine the prevalence of impaired awareness of hypoglycaemia (IAH) and examine risk factors for IAH in adults with type 1 diabetes.
Age and outcomes in people with type 2 diabetes admitted to hospital with COVID-19: A cohort study
Ni'Man M, Ruan Y, Davies J, Harris S, Nagi D, Narendran P, Field BCT, Idris I, Patel D, Rea R, Ryder REJ, Wild SH, Várnai KA, Wilmot EG and Khunti K
Severe hypoglycaemia and diabetic ketoacidosis in adults presenting to a hospital emergency department: Adverse prognostic markers for survival in type 2 diabetes and the role of SGLT2 inhibitors
Song SH and Frier BM
To determine the prognosis associated with severe hypoglycaemia (SH) and diabetic ketoacidosis (DKA) in adults presenting to a hospital emergency department (ED).
The impact of the dose adjustment for normal eating (DAFNE) structured education programme on health outcomes and healthcare costs for people with type 1 diabetes in Ireland
Sharma S, Gillespie P, Hobbins A and Dinneen SF
Pathophysiology of vascular ageing and the effect of novel cardio-renal protective medications in preventing progression of chronic kidney disease in people living with diabetes
Fountoulakis N, Miyamoto Y, Pavkov ME, Karalliedde J and Maltese G
Among people with diabetes those with chronic kidney disease (CKD) have a reduced life expectancy with increased risk of cardiovascular disease (CVD) a major contributor to morbidity and mortality. CKD related to diabetes is growing worldwide and is one of the leading causes of kidney failure globally. Diabetes is associated with accelerated vascular ageing and the related mechanisms and mediators that drive the progression of CKD and CVD disease in people with diabetes may help provide insights into the pathophysiology of cardio-renal complications and guide treatment interventions in people with diabetes.
Interventions in women with type 2 diabetes mellitus in the pre-pregnancy, pregnancy and postpartum periods to optimise care and health outcomes: A systematic review
Gunabalasingam S, Kyrka A, Hopkins L, Lebrett R, Dyer E, Forde R, Heslehurst N, Meek CL, Schoenaker DAJM, Flynn AC and White SL
Type 2 diabetes is a chronic condition affecting increasing numbers of women of reproductive age. Recent UK data show more severe adverse offspring outcomes (stillbirth, neonatal death) than in infants of those with Type 1 diabetes. This systematic review aimed to evaluate randomised controlled trials (RCTs) undertaken in the pre-pregnancy, pregnancy and the postpartum periods in women with Type 2 diabetes, to optimise care and health outcomes.
Omnipod 5 outcomes comparing Dexcom G6 and Freestyle Libre 2 plus users in adults with type 1 diabetes
Stimson RH, Dover AR, Lyall MJ, Kyle CJ, Wright RJ, McRobert G, Strachan MWJ and Gibb FW
The practical operation and consequences of glucose measurement by pilots with diabetes
Fan KS, Manoli A, Shojaee-Moradie F, Hutchison E, Strollo F, Koehler G, Mader JK, Russell-Jones D and
Explanatory variables of objectively measured physical activity, sedentary behaviour and sleep in adults with type 1 diabetes: A systematic review
Bogaert L, Dirinck E, Calders P, Helleputte S, Lapauw B, Marlier J, Verbestel V and De Craemer M
This systematic review aimed to summarize knowledge on explanatory variables of PA, SB and sleep in adults with T1D to support the development of healthy lifestyle interventions.
The effect of high-fibre diets on glycaemic control in women with diabetes in pregnancy: A systematic review and meta-analysis
Jones D, Kyriakidou A, Cooper L, Atta N, Tobolska P, Smith S, Turner E, Petry C, Gillies C and Meek CL
Dietary fibre improves glycaemic control in type 2 diabetes, but its therapeutic role in women with diabetes in pregnancy is unclear. We assessed the effect of dietary fibre on markers of glycaemic control in women with diabetes in pregnancy.
Acceptability and psychometric properties of four scales assessing the impact of Type 2 diabetes on quality of life-Results of 'YourSAY: Quality of Life'
Holmes-Truscott E, Broadley MM, Søholm U, Cooke DD, Hendrieckx C, Coates EJ, Heller SR and Speight J
To assess and compare the psychometric properties and acceptability of four diabetes-specific quality of life (QoL) scales among adults with Type 2 diabetes (T2D).